| Literature DB >> 32904133 |
Jun-Hwan Lee1,2, Kyungsun Han1, Tae-Hun Kim3, Ae-Ran Kim1, Ojin Kwon1, Joo-Hee Kim1,4, Jeong-Eun Kim1, Seunghoon Lee5, Mi-Suk Shin1,6, So-Young Jung1, Hyo-Ju Park1, Sanghun Lee7,2.
Abstract
BACKGROUND: Dry eye syndrome is the most common complication of refractive surgery. Acupuncture is widely used for the treatment of ophthalmologic diseases, but to date, few have explored the effects of acupuncture for the treatment of this condition following refractive surgery. The objective of this study is to assess the feasibility of a study design for evaluating the effectiveness of acupuncture treatment along with usual care compared with usual care only for dry eye syndrome after refractive surgery.Entities:
Keywords: Acupuncture; Clinical trial; Dry eye syndromes; Pilot study; Refractive surgery
Year: 2020 PMID: 32904133 PMCID: PMC7452177 DOI: 10.1016/j.imr.2020.100456
Source DB: PubMed Journal: Integr Med Res ISSN: 2213-4220
Fig. 1The flow diagram according to the Consolidated Standards of Reporting Trials (CONSORT) statement.
The Baseline Characteristics of the Participants
| Characteristics | Acupuncture group ( | Usual care group ( | |
|---|---|---|---|
| Age (year) | 23.67 (20.06, 27.27) | 24.67 (19.98, 29.36) | 0.7019 |
| Sex (M/F) | 3 (33.3%)/6 (66.7%) | 1 (11.1%)/8 (88.9%) | 0.5765 |
| Duration of symptoms (month) | 6.33 (2.63, 10.04) | 8.78 (3.71, 13.84) | 0.3825 |
| Computer or TV use (hour/week) | 22.11 (8.58, 35.64) | 24.39 (9.07, 39.71) | 0.8005 |
| Smoking/Non-smoking | 2 (22.2%)/7 (77.8%) | 0 (0.0%)/9 (100.0%) | 0.4706 |
| Previous treatment (frequency) | |||
| Artificial tears use | 9 (100.0%) | 9 (100.0%) | 0.9999 |
| Other treatment use | 5 (55.6%) | 4 (44.4%) | 0.9999 |
| No-treatment | 0 (0.0%) | 0 (0.0%) | 0.9999 |
| Past history related to dry eye (frequency) | |||
| Conjunctivitis | 1 (11.1%) | 0 (0.0%) | 0.9999 |
| Usage frequency of the usual care items (within the last month) | |||
| Artificial tears use | 4 (44.4%) | 6 (66.7%) | 0.6372 |
| Other treatment use | 1 (11.1%) | 4 (44.4%) | 0.1312 |
| No-treatment | 4 (44.4%) | 1 (11.1%) | 0.2941 |
Data shown in mean (95% Confidence Interval or percentage).
Independent sample t-test.
Fisher's exact test.
Changes in Ocular Symptoms and Quality of Life.
| Acupuncture group (95% CI) | Usual care group (95% CI) | Adjusted difference | Partial eta-square ( | |
|---|---|---|---|---|
| Baseline (week 0) | 40.65 (31.20, 50.11) | 42.82 (29.10, 56.55) | ||
| Intervention (week 3) | 35.12 (24.35, 45.89) | 41.23 (26.78, 55.68) | −4.08 (−12.64, 4.49) | 0.06 |
| Intervention (week 5) | 27.38 (14.77, 39.98) | 48.76 (34.66, 62.85) | −19.24 (−28.10, −10.38)* | 0.58 |
| Follow-up (week 13) | 30.60 (19.18, 42.01) | 40.00 (26.01, 53.99) | −7.85 (−20.82, 5.11) | 0.10 |
| Baseline (week 0) | 67.67 (59.40, 75.94) | 62.67 (48.72, 76.61) | ||
| Intervention (week 3) | 58.67 (42.81, 74.53) | 53.00 (34.71, 71.29) | 0.59 (−16.63, 17.82) | 0.00 |
| Intervention (week 5) | 46.89 (28.25, 65.53) | 60.00 (39.90, 80.10) | −16.76 (−40.74, 7.23) | 0.13 |
| Follow-up (week 13) | 53.67 (38.18, 69.15) | 50.33 (34.80, 65.87) | −1.41 (−16.57, 13.74) | 0.00 |
| Baseline (week 0) | 3.67 (3.00, 4.33) | 3.56 (2.53, 4.58) | ||
| Intervention (week 3) | 3.11 (2.51, 3.71) | 3.33 (2.32, 4.35) | −0.26 (−1.30, 0.77) | 0.02 |
| Intervention (week 5) | 2.67 (1.81, 3.53) | 3.78 (2.78, 4.78) | −1.15 (−2.34, 0.04) | 0.22 |
| Follow-up (week 13) | 3.00 (2.23, 3.77) | 3.33 (2.39, 4.27) | −0.36 (−1.49, 0.78) | 0.03 |
Analysis of Covariance (ANCOVA) was used for the statistical analysis of the OSDI, ocular discomfort, and QOL between-group changes from the baseline. All outcomes were adjusted for the baseline values. Negative values of the adjusted differences in OSDI, ocular discomfort, and QOL favor the acupuncture group; * p-value = 0.0003; CI, Confidence Interval; OSDI, Ocular Surface Disease Index; VAS, Visual Analog; QOL, Quality of Life
Changes in the Ophthalmologic Tests After 4 Weeks of Intervention and 8 Weeks Follow-up
| Acupuncture group (95% CI) | Usual care group (95% CI) | Adjusted difference | Partial eta-square ( | ||
|---|---|---|---|---|---|
| Left | Baseline (week 0) | 5.11 (3.46, 6.76) | 6.11 (4.70, 7.52) | ||
| Follow-up (week 13) | 6.44 (4.64, 8.25) | 6.56 (5.11, 8.00) | 0.70 (−0.77, 2.18) | 0.06 | |
| Right | Baseline (week 0) | 5.44 (4.05, 6.84) | 6.89 (5.48, 8.30) | ||
| Follow-up (week 13) | 7.00 (4.57, 9.43) | 7.11 (5.10, 9.12) | 1.41 (−1.03, 3.86) | 0.09 | |
| Left | Baseline (week 0) | 1.78 (1.14, 2.42) | 1.33 (0.67, 2.00) | ||
| Follow-up (week 13) | 1.33 (0.67, 2.00) | 1.22 (0.58, 1.86) | −0.24 (−0.81, 0.34) | 0.05 | |
| Right | Baseline (week 0) | 1.67 (0.90, 2.44) | 1.33 (0.67, 2.00) | ||
| Follow-up (week 13) | 1.33 (0.67, 2.00) | 1.11 (0.51, 1.71) | −0.01 (−0.55, 0.53) | 0 | |
| Left | Baseline (week 0) | 5.22 (2.86, 7.58) | 7.00 (4.26, 9.74) | ||
| Follow-up (week 13) | 5.44 (2.89, 8.00) | 6.33 (3.76, 8.91) | −0.54 (−4.07, 2.99) | 0.01 | |
| Right | Baseline (week 0) | 6.67 (3.00, 10.33) | 6.56 (4.88, 8.24) | ||
| Follow-up (week 13) | 4.78 (2.48, 7.08) | 6.44 (3.42, 9.47) | −1.73 (−4.61, 1.15) | 0.1 | |
Analysis of Covariance (ANCOVA) was used for the statistical analysis of the TFBUT, CSP, and Schirmer 1 test between-group changes from baseline. All outcomes were adjusted for baseline values. Negative values of the adjusted differences CSP and Schirmer values (positive difference in TFBUT) favor the acupuncture group. CI, Confidence Interval; TFBUT, Tear film break-up time; CSP, Corneal surface photography